Latest Michael Kaplitt Stories

2011-03-17 12:32:49

Results from the first successful phase 2 clinical trial of gene therapy for Parkinson's or any neurologic disorder A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson's patients, according to results of a Phase 2 study published today in the journal Lancet Neurology. The approach introduces a gene into the brain to normalize chemical signaling. The study is the first successful randomized, double-blind clinical trial of a gene therapy for Parkinson's or any...

2010-10-21 00:49:56

NewYork-Presbyterian/Weill Cornell paper reports that restoring a crucial gene in a tiny area of the brain reverses depression-like behavior in mice; human data back up the promise of such therapy In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional...

Word of the Day
  • Boughs or branches.
  • Warbling of birds in trees.